As of 2025-09-17, the Relative Valuation of Emergent BioSolutions Inc (EBS) is 35.63 USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.83 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is 355.0%.
The range of the Relative Valuation is 34.67 - 37.13 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.3x - 14.2x | 13.8x |
| Forward P/E multiples | 13.3x - 13.7x | 13.5x |
| Fair Price | 34.67 - 37.13 | 35.63 |
| Upside | 342.8% - 374.2% | 355.0% |
| Date | P/E |
| 2025-09-16 | 2.99 |
| 2025-09-15 | 3.06 |
| 2025-09-12 | 3.11 |
| 2025-09-11 | 3.15 |
| 2025-09-10 | 3.05 |
| 2025-09-09 | 3.16 |
| 2025-09-08 | 2.89 |
| 2025-09-05 | 2.90 |
| 2025-09-04 | 2.92 |
| 2025-09-03 | 2.99 |
| 2025-09-02 | 3.14 |
| 2025-08-29 | 3.17 |
| 2025-08-28 | 3.21 |
| 2025-08-27 | 3.29 |
| 2025-08-26 | 3.33 |
| 2025-08-25 | 3.52 |
| 2025-08-22 | 3.53 |
| 2025-08-21 | 3.56 |
| 2025-08-20 | 3.54 |
| 2025-08-19 | 3.51 |
| 2025-08-18 | 3.47 |
| 2025-08-15 | 3.38 |
| 2025-08-14 | 3.37 |
| 2025-08-13 | 3.36 |
| 2025-08-12 | 3.41 |
| 2025-08-11 | 3.12 |
| 2025-08-08 | 3.28 |
| 2025-08-07 | 3.15 |
| 2025-08-06 | 2.31 |
| 2025-08-05 | 2.33 |
| 2025-08-04 | 2.28 |
| 2025-08-01 | 2.15 |
| 2025-07-31 | 2.25 |
| 2025-07-30 | 2.32 |
| 2025-07-29 | 2.49 |
| 2025-07-28 | 2.59 |
| 2025-07-25 | 2.74 |
| 2025-07-24 | 2.86 |
| 2025-07-23 | 2.93 |
| 2025-07-22 | 2.74 |
| 2025-07-21 | 2.65 |
| 2025-07-18 | 2.65 |
| 2025-07-17 | 2.78 |
| 2025-07-16 | 2.67 |
| 2025-07-15 | 2.65 |
| 2025-07-14 | 2.79 |
| 2025-07-11 | 2.81 |
| 2025-07-10 | 2.80 |
| 2025-07-09 | 2.80 |
| 2025-07-08 | 2.63 |